149 related articles for article (PubMed ID: 38455854)
1. The skin as a window to the gut: A case of carcinoid syndrome.
Costa CA; Lopes T; Rodrigues AP; Lamas NJ; Cruz C
Clin Case Rep; 2024 Mar; 12(3):e8641. PubMed ID: 38455854
[TBL] [Abstract][Full Text] [Related]
2. Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report.
Kudelka MR; Abou-Alfa GK; O'Reilly EM; Foote MB; Sirohi B; Elias R; Shamseddine A; Paroder V; Moussa AM; Cohen P; Ganesh K
J Gastrointest Oncol; 2023 Aug; 14(4):1878-1886. PubMed ID: 37720425
[TBL] [Abstract][Full Text] [Related]
3. High-dose lanreotide in the treatment of poorly differentiated pancreatic neuroendocrine carcinoma: a case report.
Van Fraeyenhove F; Meireson N; Terriere L; Willemsen P; Kunnen J; Mattelaer C; Van Acker F; Schrijvers D
Case Rep Oncol; 2014 Jan; 7(1):155-63. PubMed ID: 24707264
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors.
Molina-Cerrillo J; Alonso-Gordoa T; Martínez-Sáez O; Grande E
Oncologist; 2016 Jun; 21(6):701-7. PubMed ID: 27107003
[TBL] [Abstract][Full Text] [Related]
5. Intraindividual comparison of
Ouvrard E; Chevalier E; Addeo P; Sahakian N; Detour J; Goichot B; Bachellier P; Karcher G; Taïeb D; Imperiale A
Clin Endocrinol (Oxf); 2021 Jan; 94(1):66-73. PubMed ID: 32790887
[TBL] [Abstract][Full Text] [Related]
6. Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.
Kiesewetter B; Duan H; Lamm W; Haug A; Riss P; Selberherr A; Scheuba C; Raderer M
Oncologist; 2019 Feb; 24(2):255-258. PubMed ID: 30171068
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Detoxsan
Langbein T; Dathe W; Deuerling A; Baum RP
World J Gastroenterol; 2019 May; 25(17):2133-2143. PubMed ID: 31114139
[TBL] [Abstract][Full Text] [Related]
8. Management of Diarrhea in Patients With Carcinoid Syndrome.
Naraev BG; Halland M; Halperin DM; Purvis AJ; OʼDorisio TM; Halfdanarson TR
Pancreas; 2019 Sep; 48(8):961-972. PubMed ID: 31425482
[TBL] [Abstract][Full Text] [Related]
9. Infection with multidrug-resistant Campylobacter coli mimicking recurrence of carcinoid syndrome: a case report of a neuroendocrine tumor patient with repeated diarrhea.
Lagler H; Kiesewetter B; Raderer M
BMC Infect Dis; 2016 Aug; 16():409. PubMed ID: 27519265
[TBL] [Abstract][Full Text] [Related]
10. Grade 3 Neuroendocrine Tumor (G3 NET) in a Background of Multiple Serotonin Cell Neoplasms of the Ileum Associated with Carcinoid Syndrome and Aggressive Behavior.
Capuano F; Grami O; Pugliese L; Paulli M; Pietrabissa A; Solcia E; Vanoli A
Endocr Pathol; 2018 Dec; 29(4):369-373. PubMed ID: 30076568
[TBL] [Abstract][Full Text] [Related]
11. [The ectopic ACTH syndrome].
Penezić Z; Savić S; Vujović S; Tatić S; Ercegovac M; Drezgićc M
Srp Arh Celok Lek; 2004; 132(1-2):28-32. PubMed ID: 15227962
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from
Thuillier P; Liberini V; Grimaldi S; Rampado O; Gallio E; Santi B; Arvat E; Piovesan A; Filippi R; Abgral R; Molinari F; Deandreis D
J Nucl Med; 2022 Jul; 63(7):1014-1020. PubMed ID: 34740949
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. A 17-year-old male with a Small Bowel Neuroendocrine Tumor: flushing differential diagnosis.
Forero Molina MA; Garcia E; Gonzalez-Devia D; García-Duperly R; Vera A
World Allergy Organ J; 2017; 10(1):30. PubMed ID: 28904734
[TBL] [Abstract][Full Text] [Related]
15. Rare Presentation of a Metastatic Pancreatic Neuroendocrine Neoplasm Presenting with Atrial Flutter.
Fragkou PC; Papadopoulos IA; Papadopoulos A; Kontoveros EA; Kaltsas G; Vassilara F
Eur J Case Rep Intern Med; 2021; 8(1):002216. PubMed ID: 33585343
[TBL] [Abstract][Full Text] [Related]
16. Use of somatostatin analog in management of carcinoid syndrome.
Vinik A; Moattari AR
Dig Dis Sci; 1989 Mar; 34(3 Suppl):14S-27S. PubMed ID: 2920654
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review.
Khan MS; Walter T; Buchanan-Hughes A; Worthington E; Keeber L; Feuilly M; Grande E
World J Gastroenterol; 2020 Aug; 26(30):4537-4556. PubMed ID: 32874063
[TBL] [Abstract][Full Text] [Related]
18. Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea.
Masab M; Saif MW
Cancer Chemother Pharmacol; 2017 Dec; 80(6):1055-1062. PubMed ID: 29051994
[TBL] [Abstract][Full Text] [Related]
19. Management of carcinoid syndrome: a systematic review and meta-analysis.
Hofland J; Herrera-Martínez AD; Zandee WT; de Herder WW
Endocr Relat Cancer; 2019 Mar; 26(3):R145-R156. PubMed ID: 30608900
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
